Ex-Trump Official Backs Medicare Coverage for Wegovy, Rejects Price Negotiation
2025-01-17

STAT
A former Trump administration health official, Joe Grogan, has expressed support for the Biden proposal to have Medicare and Medicaid cover GLP-1 weight-loss drugs like Wegovy. However, Grogan disagrees with the idea of subjecting Wegovy to price controls, citing concerns over the impact on pharmaceutical innovation and patient access to affordable healthcare solutions. As the US healthcare system grapples with obesity and related issues, the debate around medication coverage and pricing continues, with key considerations including healthcare policy, pharmaceutical pricing, and patient outcomes.